Literature DB >> 29472044

Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Summary of Recommendations.

Joan Albert Barberà1, Antonio Román2, Miguel Ángel Gómez-Sánchez3, Isabel Blanco4, Remedios Otero5, Raquel López-Reyes6, Isabel Otero7, Gregorio Pérez-Peñate8, Ernest Sala9, Pilar Escribano10.   

Abstract

Pulmonary hypertension is a hemodynamic disorder defined by abnormally high pulmonary artery pressure that can occur in numerous diseases and clinical situations. The causes of pulmonary hypertension are classified into 5 major groups: arterial, due to left heart disease, due to lung disease and/or hypoxemia, chronic thromboembolic, with unclear and/or multifactorial mechanisms. This is a brief summary of the Guidelines on the Diagnostic and Treatment of Pulmonary Hypertension of the Spanish Society of Pulmonology and Thoracic Surgery. These guidelines describe the current recommendations for the diagnosis and treatment of the different pulmonary hypertension groups.
Copyright © 2017 SEPAR. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Chronic thromboembolic pulmonary hypertension; Circulación pulmonar; Clinical guidelines; Guía clínica; Hipertensión arterial pulmonar; Hipertensión pulmonar; Hipertensión pulmonar tromboembólica crónica; Pulmonary arterial hypertension; Pulmonary circulation; Pulmonary hypertension

Mesh:

Year:  2018        PMID: 29472044     DOI: 10.1016/j.arbres.2017.11.014

Source DB:  PubMed          Journal:  Arch Bronconeumol (Engl Ed)        ISSN: 0300-2896            Impact factor:   4.872


  12 in total

1.  Orphan Drug Use in Patients With Rare Diseases: A Population-Based Cohort Study.

Authors:  Francesca Gorini; Michele Santoro; Anna Pierini; Lorena Mezzasalma; Silvia Baldacci; Elena Bargagli; Alessandra Boncristiano; Maurizia Rossana Brunetto; Paolo Cameli; Francesco Cappelli; Giancarlo Castaman; Barbara Coco; Maria Alice Donati; Renzo Guerrini; Silvia Linari; Vittoria Murro; Iacopo Olivotto; Paola Parronchi; Francesca Pochiero; Oliviero Rossi; Barbara Scappini; Andrea Sodi; Alessandro Maria Vannucchi; Alessio Coi
Journal:  Front Pharmacol       Date:  2022-05-16       Impact factor: 5.988

Review 2.  Advances in the Study of Inhaled Formulations for the Treatment of Pulmonary Arterial Hypertension.

Authors:  Fei Han; Yongqi Chen; Shijie Li; Yankun Yang; Zhonghu Bai
Journal:  Appl Bionics Biomech       Date:  2022-06-02       Impact factor: 1.664

Review 3.  The progress of pulmonary artery denervation.

Authors:  Yonghui Xie; Na Liu; Zhenghui Xiao; Fang Yang; Yunhong Zeng; Zhou Yang; Yuanxi Xia; Zhi Chen; Yunbin Xiao
Journal:  Cardiol J       Date:  2021-01-13       Impact factor: 3.487

Review 4.  Idiopathic Pulmonary Fibrosis: Epidemiology, Natural History, Phenotypes.

Authors:  Jaume Sauleda; Belén Núñez; Ernest Sala; Joan B Soriano
Journal:  Med Sci (Basel)       Date:  2018-11-29

5.  The era of clinical application of gene diagnosis in cardiovascular diseases is coming.

Authors:  Yu-Bao Zou; Ru-Tai Hui; Lei Song
Journal:  Chronic Dis Transl Med       Date:  2020-01-17

Review 6.  Mesenchymal stem cell-derived small extracellular vesicles in the treatment of human diseases: Progress and prospect.

Authors:  Jie Shi; Yu-Chen Zhao; Zhi-Fang Niu; Hao-Jun Fan; Shi-Ke Hou; Xiao-Qin Guo; Lu Sang; Qi Lv
Journal:  World J Stem Cells       Date:  2021-01-26       Impact factor: 5.326

7.  The Prevalence of Pulmonary Hypertension Among Maintenance Dialysis Patients With ESRD and Its Associated Factors: A Retrospective Study.

Authors:  Ying Zhang; Xiao-Han Ding; Rongsheng Rao; Yiqin Wang; Fang Pang; Sha Tang; Ling Nie; Shi-Zhu Bian
Journal:  Front Med (Lausanne)       Date:  2020-12-04

8.  Continuous epidural anesthesia with double catheters for cesarean section in a patient with severe pulmonary hypertension: A case report.

Authors:  Pingzhu Wang; Xiaojing Chen; Jingwen Zhang; Yushan Ma
Journal:  Medicine (Baltimore)       Date:  2021-11-24       Impact factor: 1.817

9.  Pulmonary hypertension among maintenance hemodialysis patients in Somalia: a hospital-based observational study.

Authors:  Gökhan Alıcı; Mohamud Mire Waberi; Mohamed Abdullahi Mohamud; Ahmed Muhammad Bashir; Ömer Genç
Journal:  Egypt Heart J       Date:  2022-04-08

10.  Tetramethylpyrazine Improves Monocrotaline-Induced Pulmonary Hypertension through the ROS/iNOS/PKG-1 Axis.

Authors:  Dong-Peng Yang; Wen-Peng Dong; Yong-Chao Yang; Yuan-Yuan Zeng; Ying Liu; Zhu Dong; Xi-Miao Ma; Yi-Qiu Cao; Yi-Zhou Bai; Bo Yang; Xiao-Wu Wang
Journal:  J Healthc Eng       Date:  2022-03-24       Impact factor: 2.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.